A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer

BACKGROUND: The present phase II study aimed to assess the feasibility and efficacy of a new paclitaxel-based neoadjuvant chemoradiation regimen followed by surgery in patients with stage II–III esophageal cancer. METHODS: From January 2002 to November 2004, 50 patients with a potentially resectable...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Schoot, L., Romme, E. A. P. M., van der Sangen, M. J., Creemers, G. J., van Lijnschoten, G., van Driel, O. J. Repelaer, Rutten, H. J. T., Nieuwenhuijzen, G. A. P.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Gastrointestinal Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190342/
https://www.ncbi.nlm.nih.gov/pubmed/17896144
http://dx.doi.org/10.1245/s10434-007-9582-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190342/
https://www.ncbi.nlm.nih.gov/pubmed/17896144
http://dx.doi.org/10.1245/s10434-007-9582-6

Ejemplares similares